← All companies

Phases

Active

Automated clinical trial oversight and execution

S25·Summer 2025·Healthcare·San Francisco, CA, USA·Team of 3·Founded 2025

About

Phases deploys AI agents to oversee clinical trials, improving operational performance, data quality, and audit readiness by identifying risks and taking actions autonomously to solve issues.

Founders

  • James Wall· Co-founder & CEO

    Accelerating & automating clinical trials with AI Agents. - Designed and deployed AI data science agents to Fortune 100 companies and pharma companies such as J&J, Syneos Health. - Built the business case that led to Unilever’s €8bn ice cream division spin-off.

  • Anton Zaliznyi· Co-founder & Chief AI Officer

    Accelerating & automating clinical trials with AI Agents. Ex SWE at Palantir, AI Researcher at University of Toronto. - Streamlined developer and deployment experiences at Palantir. - Co-authored peer-reviewed deep learning research on real-time surgical microrobot pose estimation that outperforms SOTA (Accepted to RA-L / ICRA). - Built autonomous reconnaissance drones at a defense startup. - Developed advanced distributed processing systems at Avid.

  • Jonathan van Wersch· Co-founder & CTO

    Accelerating & automating clinical trials with AI agents. - Previously a software engineer at Meta, where I worked on integrating machine learning into the mobile ads manager app. - Before Meta, I was at Improbable, a UK unicorn, where I helped scale the web platform team from 3 to 20 engineers. - I hold a bachelors and masters in mechanical engineering from the University of Bath, where I was project manager and engineering lead for the university's rocket team.

Product launches · 1 launch

Change history · none recorded

No changes recorded yet. Subsequent syncs will populate this timeline as fields drift.